BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 21196177)

  • 1. Molecular imaging metrics to evaluate response to preclinical therapeutic regimens.
    Smith RA; Guleryuz S; Manning HC
    Front Biosci (Landmark Ed); 2011 Jan; 16(2):393-410. PubMed ID: 21196177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular imaging using PET for breast cancer.
    Kurihara H; Shimizu C; Miyakita Y; Yoshida M; Hamada A; Kanayama Y; Yonemori K; Hashimoto J; Tani H; Kodaira M; Yunokawa M; Yamamoto H; Watanabe Y; Fujiwara Y; Tamura K
    Breast Cancer; 2016 Jan; 23(1):24-32. PubMed ID: 25917108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular imaging of proliferation in vivo: positron emission tomography with [18F]fluorothymidine.
    Buck AK; Herrmann K; Shen C; Dechow T; Schwaiger M; Wester HJ
    Methods; 2009 Jun; 48(2):205-15. PubMed ID: 19318128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of Tumor Angiogenesis for Radiologists--Part 1: Biological and Technical Basis.
    García-Figueiras R; Padhani AR; Beer AJ; Baleato-González S; Vilanova JC; Luna A; Oleaga L; Gómez-Caamaño A; Koh DM
    Curr Probl Diagn Radiol; 2015; 44(5):407-24. PubMed ID: 25890454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging pharmacodynamics in oncology: the potential significance of "flares".
    Trigonis I; Jackson A
    Ann Nucl Med; 2010 Apr; 24(3):137-47. PubMed ID: 20069468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography imaging of cancer biology: current status and future prospects.
    Chen K; Chen X
    Semin Oncol; 2011 Feb; 38(1):70-86. PubMed ID: 21362517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of Tumor Metabolism Using Positron Emission Tomography (PET).
    Apostolova I; Wedel F; Brenner W
    Recent Results Cancer Res; 2016; 207():177-205. PubMed ID: 27557539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional response imaging following neoadjuvant therapy for rectal cancer.
    Smeets P; Ceelen W
    Surg Technol Int; 2009 Apr; 18():93-7. PubMed ID: 19579194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Imaging of Breast Cancer: Role of RGD Peptides.
    Chakravarty R; Chakraborty S; Dash A
    Mini Rev Med Chem; 2015; 15(13):1073-94. PubMed ID: 26349490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidine Kinase PET Reporter Gene Imaging of Cancer Cells In Vivo.
    McCracken MN
    Methods Mol Biol; 2018; 1790():137-151. PubMed ID: 29858789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness research for molecular imaging.
    Graham MM
    J Comp Eff Res; 2012 Mar; 1(2):113-4. PubMed ID: 24237368
    [No Abstract]   [Full Text] [Related]  

  • 12. Preclinical FLT-PET and FDG-PET imaging of tumor response to the multi-targeted Aurora B kinase inhibitor, TAK-901.
    Cullinane C; Waldeck KL; Binns D; Bogatyreva E; Bradley DP; de Jong R; McArthur GA; Hicks RJ
    Nucl Med Biol; 2014 Feb; 41(2):148-54. PubMed ID: 24332383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular imaging using positron emission tomography in colorectal cancer.
    Lin M
    Discov Med; 2011 May; 11(60):435-47. PubMed ID: 21616042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of PET imaging with the proliferation marker [18F]-FLT.
    Peck M; Pollack HA; Friesen A; Muzi M; Shoner SC; Shankland EG; Fink JR; Armstrong JO; Link JM; Krohn KA
    Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):95-104. PubMed ID: 25737423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualization, imaging and new preclinical diagnostics in radiation oncology.
    Cyran CC; Paprottka PM; Eisenblätter M; Clevert DA; Rist C; Nikolaou K; Lauber K; Wenz F; Hausmann D; Reiser MF; Belka C; Niyazi M
    Radiat Oncol; 2014 Jan; 9():3. PubMed ID: 24387195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of cross-sectional and molecular imaging studies in the localization of gastroenteropancreatic neuroendocrine tumors.
    Toumpanakis C; Kim MK; Rinke A; Bergestuen DS; Thirlwell C; Khan MS; Salazar R; Oberg K
    Neuroendocrinology; 2014; 99(2):63-74. PubMed ID: 24458014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Functional imaging of tumors. Part 2].
    García Figueiras R; Padhani AR; Vilanova JC; Goh V; Villalba Martín C
    Radiologia; 2010; 52(3):208-20. PubMed ID: 20304448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation status of thymidine kinase 1 following antiproliferative drug treatment mediates 3'-deoxy-3'-[18F]-fluorothymidine cellular retention.
    Sala R; Nguyen QD; Patel CB; Mann D; Steinke JH; Vilar R; Aboagye EO
    PLoS One; 2014; 9(7):e101366. PubMed ID: 25003822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of new imaging techniques to predict tumour response to therapy.
    Harry VN; Semple SI; Parkin DE; Gilbert FJ
    Lancet Oncol; 2010 Jan; 11(1):92-102. PubMed ID: 20129132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.